MedTrace Logo

Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

NCT07108062 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2026-04-07

No results posted yet for this study

Summary

Objective:

To evaluate the effectiveness of telerehabilitation (via lifestyle and dietary advice) in managing primary nocturnal enuresis (bedwetting) in children aged 5-10 years.

Background:

Nocturnal enuresis is common in children and can be influenced by genetic, hormonal, and bladder-related factors. Treatment includes behavioral, pharmacological, and psychological approaches. Telerehabilitation-remote delivery of care-emerged during the COVID-19 pandemic as a promising tool for maintaining continuity of care.

Methodology:

Design: Randomized Controlled Trial

Participants: Children aged 5-10 with primary NE (wetting ≥4 nights/week), recruited online.

Exclusion: Children with secondary NE due to medical conditions or those on medication.

Groups:

Study group: Received telerehabilitation (lifestyle + dietary guidance).

Control group: No telerehabilitation.

Duration: 3 weeks (1 week baseline, 1 week intervention, 1 week follow-up)

Assessment:

Number of wet nights per week (using ICCS classification: responders, partial responders, non-responders)

Pediatric quality of life

Intervention Details:

Telerehabilitation involved dietary recommendations (e.g., reducing evening fluid intake, avoiding caffeine/chocolate), lifestyle tips, and motivational counseling delivered remotely to caregivers.

Data Analysis:

Pre- and post-intervention outcomes compared using paired t-tests. Demographics and clinical characteristics recorded.

Conditions

Interventions

OTHER

Experimental

(lifestyle + dietary advice)

OTHER

Placebo

No intervention

Sponsors & Collaborators

  • Kafrelsheikh University

    collaborator OTHER

  • Hungarian University of Sports Science

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-29
Primary Completion
2026-01-29
Completion
2026-01-29

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07108062 on ClinicalTrials.gov